tiprankstipranks
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
Holding FOLD?
Track your performance easily

Amicus (FOLD) Technical Analysis

989 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Amicus Therapeutics’s (FOLD) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Amicus Therapeutics is a Sell.
Amicus Therapeutics’s (FOLD) 20-Day exponential moving average is 9.91, while Amicus Therapeutics’s (FOLD) share price is $9.8, making it a Sell.
Amicus Therapeutics’s (FOLD) 50-Day exponential moving average is 10.25, while Amicus Therapeutics’s (FOLD) share price is $9.8, making it a Sell.

Amicus (FOLD) Pivot Points

Dec 22, 2024, 01:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.06
9.25
9.49
9.68
9.92
10.11
10.35
Fibonacci
9.25
9.41
9.52
9.68
9.84
9.95
10.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (FOLD) Moving Averages

Dec 22, 2024, 01:04 AM
Period
Simple
Exponential
MA5
9.78Buy
9.77Buy
MA10
9.85Sell
9.80Sell
MA20
9.84Sell
9.91Sell
MA50
10.49Sell
10.25Sell
MA100
10.78Sell
10.55Sell
MA200
10.64Sell
10.96Sell
Amicus Therapeutics’s (FOLD) 10-Day exponential moving average is 9.80, while Amicus Therapeutics’s (FOLD) share price is $9.8, making it a Sell.
Amicus Therapeutics’s (FOLD) 100-Day exponential moving average is 10.55, while Amicus Therapeutics’s (FOLD) share price is $9.8, making it a Sell.
Amicus Therapeutics’s (FOLD) stock price is $9.8 and Amicus Therapeutics’s (FOLD) 50-day simple moving average is 10.49, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $9.8 and Amicus Therapeutics’s (FOLD) 100-day simple moving average is 10.78, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $9.8 and Amicus Therapeutics’s (FOLD) 200-day simple moving average is 10.64, creating a Sell signal.

Amicus (FOLD) Technical Indicators

Dec 22, 2024, 01:04 AM
Name
Value
Implied Action
RSI (14)
45.87
Neutral
STOCH (9,6)
39.35
Neutral
STOCHRSI (14)
39.35
Neutral
MACD (12,26)
-0.17
Sell
ADX (14)
16.83
Buy
Williams %R
-51.39
Buy
CCI (14)
-40.68
Neutral
ATR (14)
0.38
-
Ultimate Oscillator
48.62
Neutral
ROC
-1.61
Sell
Amicus Therapeutics’s (FOLD) Relative Strength Index (RSI) is 45.87, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Trend Strength Indicator (ADX) is 16.83, creating a Buy signal.
Amicus Therapeutics’s (FOLD) Commodity Channel Index (CCI) is -40.68, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Price Rate of Change (ROC) is -1.61, creating a Sell signal.

FAQ

Is FOLD a Buy, Hold, or Sell?
Based on FOLD’s technical indicators, FOLD is a Sell.
    What is FOLD’s RSI (14)?
    FOLD’s RSI (14) is 45.87, which suggests FOLD is a Neutral.
      What is FOLD’s MACD?
      FOLD’s MACD is -0.17, which suggests FOLD is a Sell.
        What is FOLD’s 5-day moving average?
        FOLD’s 5-day moving average is 9.78, which suggests FOLD is a Buy.
          What is FOLD’s 20-day moving average?
          FOLD 20-day moving average is 9.84, which suggests FOLD is a Sell.
            What is FOLD’s 50-day moving average?
            FOLD’s 50-day moving average is 10.49, which suggests FOLD is a Sell.
              What is FOLD’s 200-day moving average?
              FOLD’s 200-day moving average is 10.64, which suggests FOLD is a Sell.
                What is FOLD’s Williams % R (14)?
                FOLD’s Williams % R (14) is -51.39, which suggests FOLD is a Buy.
                  What is FOLD’s CCI (14)?
                  FOLD’s CCI (14) is -40.68, which suggests FOLD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis